Interaction of factor VIII and von Willebrand factor and the identification of type 2 N von Willebrand disease

被引：13
|
作者：
Favaloro, Emmanuel J. [1 ]
机构：
[1] Westmead Hosp, ICPMR, Dept Haematol, WSAHS, Westmead, NSW 2145, Australia
来源：
THROMBOSIS RESEARCH | 2011年 / 127卷 / 01期
关键词：
2N NORMANDY; BINDING; ASSAY; CLASSIFICATION; SUBCOMMITTEE; HEMOSTASIS; PREVALENCE; DIAGNOSIS;
D O I：
10.1016/j.thromres.2010.11.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [1] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
  • [2] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J.
    de Jager, N.
    Hazendonk, H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Laros-van Gorkom, B.
    Leebeek, F.
    Cnossen, M.
    Mathot, R.
    [J]. HAEMOPHILIA, 2021, 27 : 147 - 147
  • [3] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease
    Bukkems, Laura H.
    Heijdra, Jessica M.
    de Jager, Nico C. B.
    Hazendonk, Hendrika C. A. M.
    Fijnvandraat, Karin
    Meijer, Karina
    Eikenboom, Jeroen C. J.
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    [J]. BLOOD ADVANCES, 2021, 5 (05) : 1513 - 1522
  • [4] Diagnosis of von Willebrand disease type 2N: A simplified method for measurement of factor VIII binding to von Willebrand factor
    Miller, CH
    Kelley, L
    Green, D
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (04) : 311 - 318
  • [5] Optimizing therapy with factor VIII von Willebrand factor concentrates in von Willebrand disease
    Federici, AB
    Mannucci, PM
    [J]. HAEMOPHILIA, 1998, 4 : 7 - 10
  • [6] Pharmacokinetics of von Willebrand factor and factor VIII in canine von Willebrand disease and haemophilia A
    Stokol, T
    Trepanier, L
    Parry, BW
    Finnin, BC
    [J]. RESEARCH IN VETERINARY SCIENCE, 1997, 63 (01) : 23 - 27
  • [7] Pharmacokinetics of von Willebrand factor and factor VIII coagulant activity in patients with von Willebrand disease type 3 and type 2
    Menache, D
    [J]. HAEMOPHILIA, 1998, 4 : 44 - 47
  • [8] IMPACT OF ANEMIA ON VON WILLEBRAND FACTOR AND FACTOR VIII IN TYPE 1 VON WILLEBRAND DISEASE AND MILD HEMOPHILIA
    Febres, Maria E. Carter
    Tarango, Cristina
    Fenchel, Matthew
    Pomales, Jennifer
    Mullins, Eric
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E18 - E18
  • [9] Impact of obesity on factor VIII and von Willebrand factor levels in patients with Type 1 von Willebrand disease and low von Willebrand factor: An analysis of the ATHNdataset
    Schaefer, Beverly A.
    Cheng, Dunlei
    Kouides, Peter
    [J]. HAEMOPHILIA, 2022, 28 (01) : 109 - 116
  • [10] Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice
    Swystun, L. L.
    Georgescu, I.
    Mewburn, J.
    Deforest, M.
    Nesbitt, K.
    Hebert, K.
    Dwyer, C.
    Brown, C.
    Notley, C.
    Lillicrap, D.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (08) : 1607 - 1619
12345